Version 1
: Received: 26 May 2020 / Approved: 28 May 2020 / Online: 28 May 2020 (11:33:47 CEST)
How to cite:
Khanahmad, H.; Rahimmanesh, I.; Totonchi, M. High-efficiency Non-viral Transfection of Human Primary T Lymphocytes. Preprints2020, 2020050456. https://doi.org/10.20944/preprints202005.0456.v1
Khanahmad, H.; Rahimmanesh, I.; Totonchi, M. High-efficiency Non-viral Transfection of Human Primary T Lymphocytes. Preprints 2020, 2020050456. https://doi.org/10.20944/preprints202005.0456.v1
Khanahmad, H.; Rahimmanesh, I.; Totonchi, M. High-efficiency Non-viral Transfection of Human Primary T Lymphocytes. Preprints2020, 2020050456. https://doi.org/10.20944/preprints202005.0456.v1
APA Style
Khanahmad, H., Rahimmanesh, I., & Totonchi, M. (2020). High-efficiency Non-viral Transfection of Human Primary T Lymphocytes. Preprints. https://doi.org/10.20944/preprints202005.0456.v1
Chicago/Turabian Style
Khanahmad, H., Ilnaz Rahimmanesh and Mehdi Totonchi. 2020 "High-efficiency Non-viral Transfection of Human Primary T Lymphocytes" Preprints. https://doi.org/10.20944/preprints202005.0456.v1
Abstract
The development and optimization of an effective non-viral gene delivery method for genetic manipulation of primary human T cells is a major challenge in clinical immunotherapy researches. According to the low transfection efficiency of conventional methods in human primary T cells, there is an effort in order to increase the transfection rate in these cells. Protamine is an FDA-approved compound with a documented safety profile that enhances DNA condensation for gene delivery. In this study, the effect of protamine on the transfection efficiency of standard transfection reagents, TurboFect, and Lipofectamine 2000 was evaluated in order to transfect primary human T cells. Results demonstrated that protamine condenses DNA and increases the positive charge of DNA/Cargo complex efficiently without any cytotoxic effect on the primary human T cells. The results also revealed that the DNA/Protamine/Cargo complexes effectively transfect human primary T cells.
Keywords
Human primary T cells; Cancer immunotherapy; Gene delivery; Protamine sulfate; Transfection
Subject
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.